HALO

Halozyme Therapeutics Inc (HALO)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 8.75B
P/E Ratio
17.12
Revenue (TTM)
$ 1.18B
Volume
0
52W High
$ 74.94
52W Low
$ 42.01
Dividend Yield
0.00%
Beta
1.17

Technicals

50-Day MA
61.509
200-Day MA
57.0606
52 Week High
74.94
52 Week Low
42.01

About HALO

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Employees
350
Headquarters
San Diego, CA
CEO
Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg